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Abstract
It remains a challenge to establish a straightforward genetic approach for controlling the probability of gene activation or
knockout at a desired level. Here, we developed a method termed STARS: stochastic gene activation with genetically
regulated sparseness. The stochastic expression was achieved by two cross-linked, mutually-exclusive Cre-mediated
recombinations. The stochastic level was further controlled by regulating Cre/lox reaction kinetics through varying the
intrachromosomal distance between the lox sites mediating one of the recombinations. In mammalian cell lines stably
transfected with a single copy of different STARS transgenes, the activation/knockout of reporter genes was specifically
controlled to occur in from 5% to 50% of the cell population. STARS can potentially provide a convenient way for genetic
labeling as well as gene expression/knockout in a population of cells with a desired sparseness level.
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Introduction
To address many questions in neurobiology, developmental
biology and cancer biology, it becomes more and more important
to generate genetic models in which transgene (e.g. fluorescence
markers) expression or inactivation of gene of interest occurs only
in a small number of cells. This poses two technical challenges to
molecular geneticists: first, how to manipulate gene activation in a
stochastic way; second, how to control the stochastic level of gene
activation. The establishment of such mechanisms will allow us to
achieve differential gene expression in cells with otherwise
identical ‘‘transcriptome’’ profiles, and also to control the
percentage of cells that have specific gene expression/knockout
in a block of tissue, i.e. the level of sparseness. Several genetic
methods have been developed for achieving gene expression/
knockout in a small population of cells: 1) screening transgenic
lines with variegated gene expression [1–3]; 2) CreER-lox
mediated intrachromosomal recombination [2,4–6]; and 3) Cre-
lox mediated interchromosomal recombination during mitosis [7–
12] (e.g. Mosaic analysis with double markers in mice, MADM).
The application of variegation effect depends on screening of
transgenic lines with the desired expression pattern. The method
of CreER will require careful titration of the dose of tamoxifen for
the specific tissue under examination [5,6]. As for MADM, the
required mitotic recombination, although facilitates tracing of cell
lineage, makes it less efficient to label differentiated cells. In all
these methods, a straightforward genetic control of the percentage
of cells with expression/knockout of gene of interest cannot be
readily achieved. Recently, a Brainbow transgenic strategy has
been developed [13], in which Cre/lox recombination was utilized
to create a stochastic choice of expression among three different
fluorescence proteins. Cells can be labeled with as many as tens of
different colors according to the combination of differential doses
of fluorescence proteins expressed in each cell. This method
enables imaging a large number of individual cells in the same
circuit. In the present study, by exploiting the Cre-lox mediated
intrachromosomal recombination and implementing a novel
mechanism to control the stochastic level, we developed a new
strategy for purely genetic control of gene activation with desired
sparseness.
Results and Discussion
To develop a method that can stochastically activate gene
expression with desired sparseness, we first considered the reaction
kinetics of Cre/lox-mediated intrachromosomal recombination.
There are two ways that can potentially regulate the Cre/lox
reaction kinetics. First, in vitro studies suggest that mutations in the
spacer region of loxP result in variations of recombination
efficiency [14]. However, Brainbow transgene expression in cell
lines or in vivo did not reveal apparent differences in recombination
efficiency among the three lox variants used [13]. Second, a
previous in vivo study [15] demonstrated that Cre can effectively
induce intrachromosomal recombination between two loxP sites
separated as far as several mega basepairs on mouse chromosome
11 and that this efficiency is reduced when the substrate length
increases. We hypothesize that as the length of DNA sequence
between two lox sites increases, it may take a longer time for the
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[16], which is required for recombination to occur. In this study,
we focused on the second mechanism, and designed our strategy
for stochastic gene activation/knockout with regulated sparseness
(STARS) as shown in Fig. 1a: two independent recombination
units (A and B, which contain different lox variants, lox2272 and
loxP, respectively.) are crossly linked with the first one containing
gene X and the other containing gene Y. Because Cre-mediated
recombination can only occur between two identical lox sites
[13,14,17,18], and excision by one recombination event removes a
lox site necessary for the other to occur, the choice between X and
Y expression is made stochastic and mutually exclusive (Fig. 1b).
Under our hypothesis, if the lengths of the two recombination
units (A and B) are equal, their reaction kinetics, reflected by the
rate constant k1 and k2 respectively, should be comparable and the
chances of X and Y expression should be similar. On the other
hand, if the sequence in unit A is longer than that in unit B, the
reaction time needed for excising A will be longer than that for B,
hence the recombination will be more likely to occur in B,
resulting in a higher probability of expressing gene X than Y
(Fig. 1c). Thus, by varying the length of one unit while keeping
the other constant, we can regulate the probability of the desired
recombination, and control the sparseness level of gene activation.
To test this idea, a set of constructs were made, which contained
membrane bound-GFP (M-GFP as gene X) flanked by lox2272
sites, mCherry (gene Y) flanked by loxP sites, and a spacer in unit A
of various lengths. Here, M-GFP was defined as the gene of
interest and mCherry was defined as the reporter gene. We
predicted that an increase in the spacer length would result in a
higher probability of Cre-mediated recombination in unit B,
leading to the removal of mCherry cassette. A third marker,
fluorescent protein mKusabira orange(mKO) flanked by loxN pair
Figure 1. STARS strategy. a, Schematic drawing of the structure of STARS transgene: gene X flanked by lox2272 pair (Unit A) and gene Y flanked
by loxP pair (Unit B) are crossly linked and subjected to Cre action. b, Two Cre molecules bind to each lox site and two identical lox sites are brought
together for the recombination to occur. Cre stochastically excises recombination unit A or B (the reaction kinetics reflected by the rate constant k1
and k2, respectively) and leads to mutually exclusive expression of gene Y and gene X. c, We hypothesize that the length of recombination unit may
affect the reaction kinetics and leads to differential outcomes after Cre action.
doi:10.1371/journal.pone.0004200.g001
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cassette to facilitate selection of cell lines that have the construct
integrated in the genome, and to prevent cells from expressing M-
GFP in the absence of Cre (Fig. 2a). Single copy of each of these
constructs was inserted into the same locus of HEK293 cell
genome with a targeted method (see methods). Selected stable
cell lines for each construct were transfected with the plasmid
expressing Cre recombinase and imaged five days post transfec-
tion. In the absence of Cre, all cells were mKO-positive, and no
expression of M-GFP or mCherry was observed (data not shown).
Five days after Cre transfection, cells expressing M-GFP and
mCherry were found to be separate populations, consistent with
the stochastic and mutually exclusive choice of expression and
supporting the notion that the selected cell lines had only single
copy STARS transgene in the genome (Fig. 2b). In addition, all
the cells that were either M-GFP or mCherry positive lacked
mKO fluorescence (data not shown), suggesting that 5 days is
sufficient for the turnover of mKO protein.
To examine the effect of intrachromosomal length on the
recombination efficiency, we calculated the ratio between the
number of cells expressing M-GFP and mCherry. For the cell line
containing the transgene without the spacer (STARS1-1), M-GFP
and mCherry were expressed in roughly equal number of cells
after Cre transfection (53%63% vs. 47%63%, respectively,
mean6SD) (Fig. 2b & 2c), consistent with the results of Brainbow
transgene expression [13]. Interestingly, as the length of the spacer
in unit A increased from 0 kb to 12 kb (STARS 1-1 to STAR1-
13), the number of mCherry-positive cells decreased monotoni-
cally from 47% to 5% of the total cell population, while M-GFP
positive cells increased to 95% (Fig. 2b & 2c). Here, each cell line
with a specific STARS transgene was tested five times indepen-
dently. Our data indicated that, by varying the length of DNA
fragment flanked by lox2272 sites up to 13 kb, mCherry activation
(or M-GFP knockout in another word) could be controlled to
occur in from around 50% to 5% of cells (Fig. 2c). Because all
STARS transgenes were integrated into the same locus of
HEK293 cell genome, the differential sparseness is unlikely
attributed to variations in Cre efficiency. These results support
our hypothesis that the longer DNA fragment flanked by lox pair,
the longer time it takes for Cre-mediated recombination to occur.
The relationship between the percentage of cells expressing
mCherry and the ratio between the lengths of two recombination
units can be best described with a second order exponential decay
curve (see Fig. 3). This curve may provide guidance for construct
design to achieve desired sparseness level.
Because Cre expression is not long-lasting in transfected cells,
possibility exists that some M-GFP positive cells resulted from
simple excision of the mKO unit without recombination in the
mCherry unit. This can lead to an overestimation of the number
of M-GFP expressing cells that directly result from the stochastic
Figure 2. Test of STARS. a, Schematic drawing of the STARS
construct for making HEK293 stable cell lines. CMV b-actin enhancer
(CAGGS) promoter was used to drive the expression of STARS
transgene. mKO flanked by loxN pair was used to mark the stable cell
lines and prevent the expression of M-GFP without Cre action. The
spacer following M-GFP-pA regulates the length of unit A. b, Example
images of HEK293 cells stably expressing various STARS transgenes
after Cre action. The names of STARS constructs and the corresponding
spacer length are indicated. c, Average percentage of cells expressing
mCherry (red) or M-GFP (green) in each cell population. Data from five
independent experiments for each cell line were averaged. Bars
represent standard deviation. Significant difference (p,0.02) was found
between each pair of lines except between STARS 1–5 and 1–9 (p.0.05
for 1–5 and 1–9, p,0.02 for 1–9 and 1–13, and p,0.01 for all the
remaining pairs, Tukey’s multiple comparison test, n=5).
doi:10.1371/journal.pone.0004200.g002
Figure 3. Relationship between the level of sparseness and the
ratio of length between recombination units. In our STARS
application, the gene Y in unit B was used as a reporter with a fixed
length of about 1 kb. The regulation is achieved through unit A. Here,
X-axis represents the ratio of DNA length between unit A and B. Y-axis
represents the percentage of cells expressing gene Y (mCherry). Data
point represents each individual experiment. The red curve represents
the best fit (r
2=0.97) with a second order exponential function:
y=y 0+a1* e^(2x/t1)+a2 * e^(2x/t2), where y0 is 0, a1 is 556.79, t1 is 0.32,
a2 is 23.81, t2 is 10.00.
doi:10.1371/journal.pone.0004200.g003
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estimate the number of M-GFP cells with mKO excision only
(i.e. ‘‘false’’ M-GFP cells), we sorted out M-GFP-positive cells after
Cre action by using FACS and seeded them in 96-well plates at
single-cell per well (see methods). After cells had proliferated and
expanded to colonies of thousands of cells, we further transfected
individual colonies with Cre. As ‘‘false’’ M-GFP cells have an
intact STARS cassette, Cre expression will lead to the expression
of mCherry in at least some cells of the colony. This is due to a
bona fide action of Cre on the STARS cassette. As shown in Fig. 4,
from all the colonies collected, only one colony exhibited mCherry
expressing cells. This result indicated that Cre action was in fact
highly efficient and quite complete, and that the overestimation of
M-GFP expressing cells was negligible.
STARS strategy can allow three types of applications. First, by
combining tissue or cell-type specific Cre expression, a genetic
‘‘Golgi’’-like staining of a small number of cells of a particular type
can be achieved. Second, overexpression of exogenous genes in a
small population of cells (e.g. by replacing mCherry with any gene
of interest) can be achieved. Finally, it can provide a potential way
for sparse knockout of endogenous genes with simultaneous
labeling of the cells undergoing the knockout event, e.g. in the
STARS constructs, mCherry expression can be also viewed as
GFP knockout. With STARS, the level of sparseness might not be
influenced by the locus of gene to be knocked out in the genome.
A major advantage of STARS is to be able to regulate the level
of sparseness through controlling the stochastic level of gene
activation. How sparse the STARS strategy can reach remains to
be tested. It is possible that by combining two mechanisms
adjusting reaction kinetics, i.e. by varying the length of lox-flanked
DNA fragment and mutagenizing lox sites, lower sparseness level
can be achieved. Based on the results from the present study, the
STARS strategy can be potentially applied to create genetic
mosaics for studying the population dosage of genes underlying
sporadic genetic diseases, to induce loss of heterozygosity for
modeling cancer development and screening for tumor suppressor
genes, to trace neuronal circuit and cell fate, as well as to
determine cell-autonomous function of a gene, etc. Taken
together, as a purely genetic method, STARS can be conveniently
and broadly applied, with tissue- or cell-type specificity provided
by specific Cre lines.
Methods
Generation of STARS constructs and CAGGS-Cre plasmid
All constructs were made using standard molecular cloning
methods. Briefly, CMV b-actin enhancer (CAGGS) promoter
[19,20] was digested from pCAGGS-ES plasmid (gift of Dr. Le
Ma) using restriction enzyme SpeI plus EcoRI and filled to blunt
end at EcoRI site with T4 DNA polymerase (Promega). This
Figure 4. Examination of the identities of M-GFP positive cells. After Cre action on HEK293-STARS cell lines, M-GFP positive cells were sorted
out and seeded at single cell/well in 96-well plates for proliferation. When the colonies contain thousands of cells (takes about 2 weeks), they were
transfected with the plasmid expressing Cre. Clones that have cells expressing mCherry in 5 days post transfection were counted as positive and
summarized in the table.
doi:10.1371/journal.pone.0004200.g004
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SpeI plus SmaI. To obtain lox-flanked XFP, loxN pair was
introduced in the primers amplifying mKusabira orange [21] (59
primer: ctgcagataacttcgtatagtatacctta tacgaagttataccatggtgagtgtgat-
taa, 39primer: ctgcagataacttcgtataaggtatactatacgaagttatattaa
aaaacctcccacacct) and lox2272-loxP pair was introduced in the
primers amplifying both membrane bound (M)-GFP(or lynGFP)
[22] (59 primer: agatatcctgcagataacttcgtataggatac tttatacgaagttatac-
catgggatgtattaaatca, 39primer: ccatgggaagcttataacttcgtataatgtatgcta-
tac gaagttatgaattcggccggccggcgcgccgaattcgtcgaggccgcgaattaaaaaacc)
and mCherry [23] (59 primer: ccatgggaagcttataacttcgtataggatacttta-
tacgaagttatcacgtgccaccatggtgagcaagggc gagga, 39 primer: ggaattcctc-
gagataacttcgtataatgtatgctatacgaagttatagatctgtcgaggccgcg aattaaaa-
aacc). Sequences underlined are corresponding lox sites or their
reverse complements. Polymerase chain reaction (PCR) was then
performed to generate PstI-lox2272-M-GFP-SV40polyA-EcoRI-As-
cI-FseI-EcoRI-loxP-HindIII, PstI-loxN-mKO-SV40polyA- loxN-PstI
and HindIII-lox2272-mCherry-SV40polyA-loxP-XhoI fragments,
which were sequentially inserted downstream of CAGGS promoter
in pBlue-script SK+/2 by PstI plus HindIII, PstI and HindIII plus
XhoI respectively to make STARS 1-1. We then generated multiples
of tetra-poly(A) fragment [24] (4 kb, 8 kb, 12 kb) flanked by AscI and
FseI in pCR-script plasmid and inserted these fragments or a single
poly(A)(1 kb) fragment flanked by EcoRI into the spacer of STARS1-
1 by either AscI plus FseI or EcoRI respectively to generate other
STARS constructs. To make stable HEK293 cell lines, the entire
STARS cassettes was subcloned using XhoI and NotI sites into
pcDNA5/FRT expression vector (Invitrogen) previously modified to
remove its CMV promoter. CAGGS-Cre construct was made by
subcloningCrecDNAplusHSV-TKpolyAfrompACNplasmid[25]
to pCAGGS-ES vector using EcoRI plus NotI sites.
Generation of stable HEK293 cell lines with single-copy
STARS integration
HEK293 cell lines stably transfected with single copy of various
STARS constructs were made using Flp-In
TM system (Invitrogen).
Briefly, HEK293 Flp-In cells were cultured in DMEM, containing
10% FCS, 1% penicillin/streptomycin and 100 ug/ml zeocin in a
temperature- and humidity-controlled incubator (95% air, 5% CO2
asthegasphase)at37uC.Subconfluentcellswerecotransfected with
pOG44 (Invitrogen): pcDNA/FRT/STARS at 9:1 ratio using
electroporation methods. 48 hrs after transfection, cells were split
into 10 cm tissue culture dishes and selected with 100 ug/ml
hygromycin until colonies are visible. Individual colonies were
further screened for mKO expression and picked to expand until
subconfluence for transfection. Due to the fact that Flp-In system
utilized Flp recombinase mediated transgene integration into single
Frtsite previouslyinserted inthegenomeofFlp-In
TMHEK293cells,
the clones generated should be isogenic and have single copy
integration of STARS transgenes. This is further supported by the
fact that in all tested cell lines M-GFP-positive and mCherry-
positive cells are separate populations after Cre action.
Cell Transfection, FACS sorting and data analysis
HEK293 Flp-In cells with single copy STARS integration were
cultured under conditions described above until subconfluence,
and then transfected with CAGGS-Cre plasmid using lipofecta-
mine 2000 (Invitrogen) according to the product manual. Five
days after transfection, cells were imaged with a custom-built epi-
fluorescence microscope equipped with a 106 objective (Olym-
pus). For each line with desired STARS transgene, around 800
cells were counted for each transfection and data from five
independent transfections were averaged to derive the ratio of the
number of M-GFP positive versus mCherry positive cells. In
several other experiments, we included 1 mM cytosine arabinoside
in the medium during transfection to slow down cell proliferation
as to limit potential loss of Cre plasmid during cell division. No
significant difference was observed between results with and
without cytosine arabinoside treatment. In addition, we infected
cells with lentivirus expressing CreER under CMV promoter with
a MOI (multiplicity of infection) of 8 and cultured cells in the
presence of 1.25 mM 4-hydroxy-tamoxinfen. Again, no significant
difference was observed compared to the data from Cre plasmid
transfection. The following filter sets (Chroma Technology) were
used to separate signals between GFP/mKO/mCerry channels
without detectable cross-talk: for GFP, excitation 465/37, emission
512/35, and 490DCLP; for mKO: 540/10, 570/20, and
550DCLP; for mCherry, 580/10, 630/50, and 600DCLP. Images
were analyzed and edited using Image J software.
Cells were trypsinized after imaging, suspended in PBS and
subjected to FACS sorting for M-GFP positive cells. The latter
were seeded in 96-well plates at single cell/well for expansion and
subsequent transfection. The FACS was performed using a BD
FACSAria cell sorter.
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